Back
Keros Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
KROS
Keros Therapeutics, Inc.
Last Price:
$12.02
Seasonality Move:
-17.98%
7 Day Trial
ALL ACCESS PASS
$
7
Keros Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 7.2% based on the past 6 years of stock performance.
-
Keros Therapeutics, Inc. has fallen lower in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Keros Therapeutics, Inc. Stock Undervalued?The current Keros Therapeutics, Inc. [KROS] share price is $12.00. The Score for KROS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 7.2% based on the past 6 years of stock performance.
Keros Therapeutics, Inc. Stock Rating
Buy
53
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. overpriced?
-
Keros Therapeutics, Inc. has fallen lower in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Keros Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
22.55
52-Week Low:
9.12
Prediction Charts
Market Cap:
243.2M
Price in USD:
12.00
Volume:
559K
Beta:
1.23
Technical Analysis
SMA50:
14.43
SMA100:
16.75
SMA200:
15.78
52-Wk Change:
19.52%
Stock Predictions
-
Is Keros Therapeutics, Inc. stock public?Yes, Keros Therapeutics, Inc. is a publicly traded company.
-
What is the Keros Therapeutics, Inc. stock quote today?The Keros Therapeutics, Inc. stock price is 12.00 USD today.
-
How to buy Keros Therapeutics, Inc. stock online?You can buy Keros Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 11.05 | 11.03 | 11.23 | 10.87 |
| Mar-17 | 11.03 | 11.34 | 11.40 | 11.03 |
| Mar-18 | 11.19 | 10.95 | 11.41 | 10.76 |
| Mar-19 | 10.85 | 11.12 | 11.14 | 10.57 |
| Mar-20 | 11.10 | 10.96 | 11.41 | 10.68 |
| Mar-23 | 11.00 | 11.24 | 11.28 | 10.71 |
| Mar-24 | 11.08 | 10.99 | 11.40 | 10.71 |
| Mar-25 | 11.13 | 11.34 | 11.41 | 11.13 |
| Mar-26 | 11.16 | 11.08 | 11.60 | 11.00 |
| Mar-27 | 11.07 | 10.61 | 11.07 | 10.60 |
| Mar-30 | 10.62 | 10.68 | 10.82 | 10.42 |
| Mar-31 | 10.90 | 11.04 | 11.48 | 10.90 |
| Apr-1 | 11.10 | 11.69 | 11.96 | 11.08 |
| Apr-2 | 11.42 | 12.00 | 12.03 | 11.30 |
Keros Therapeutics, Inc. Earnings
Keros Therapeutics, Inc. Earnings Report: Per Share Keros Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics, Inc. Forecast Revenue Growth
Keros Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.02 per share, a decrease this year of $7.02 per share, and a decrease next year of $0.38 per share.
* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.